Bio-Rad Laboratories | BIO - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Abbott USD 6.8B 1.72B 2026-03
Agilent USD 1.81B 49M 2026-03
Becton, Dickinson and Co. USD 708M 105M 2026-06
Bio Techne USD 209.82M 36.94M 2026-03
Bio-Rad Laboratories USD 517M 9.8M 2026-06
Bruker USD 184.9M 51.5M 2026-06
Charles River Laboratories USD 192.02M 195K 2026-06
Danaher USD 4.35B 1.35B 2026-06
General Electric Aerospace USD 9.35B 1.64B 2026-06
Illumina USD 1.09B 329M 2026-03
IQVIA Holdings USD 1.91B 38M 2026-06
Laboratory Of America USD 141.8M 839.3M 2026-06
Merck USD 6.85B 1.52B 2026-06
Mettler Toledo International USD 51.38M 9.19M 2026-06
Myriad Genetics USD 115.2M 9.2M 2026-06
OraSure Technologies USD 160.58M 16.38M 2026-06
Pacific Biosciences Of California USD 61M 4.73M 2026-06
Quest Diagnostics USD 626M 233M 2026-06
Repligen USD 606.78M 24.13M 2026-06
Revvity USD 1.02B 162.62M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Siemens EUR 8.66B 6.6B 2026-03
Standard Biotools USD 265.77M 147.56M 2026-03
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Tosoh JPY 179.62B 46.51B 2026-03
Waters USD 539M 77M 2026-06